250: SPARTAN GRAPPA ASAS SYMPOSIUM on Axial Spondyloarthritis (axSpA) and Psoriatic Arthritis (PsA)

Tuesday, November 15, 2022

7:00 AM – 9:30 AM Eastern Time

Location: Marriott, Salon A&B

All of the relevant financial relationships listed for faculty have been mitigated.

Industry Moderator(s)

MB

Mohamad Bittar, MD

The University of Tennessee Health Science Center
Memphis, TN, United States

Disclosure(s): No financial relationships to disclose
SD

Soha Dolatabadi, MD

Rheumatology Specialist
Soha Dolatabadi,MD
Los Angeles, CA, United States

Disclosure information not submitted.

Industry Presenter(s)

Marina Magrey, MD

Professor of Medicine, Division Chief of Rheumatology for University Hospitals
Case Western Reserve University School of Medicine/University Hospitals
Richfield, OH, United States

Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Consultant (Ongoing); Janssen: Consultant (Ongoing); Novartis: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing); UCB: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Alexis Ogdie, MD

Rheumatologist, Associate Professor of Medicine
University of Pennsylvania
Philadelphia, PA, United States

Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead Sciences: Consultant (Ongoing); GlaxoSmithKline: Consultant (Ongoing); Happify Health: Consultant (Ongoing); Janssen: Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing)
FV

Filip Van den Bosch, MD, PhD

Head-of-Clinic and Associate Professor of Rheumatology
Dept. of Rheumatology - Ghent University Hospital
Gent, Belgium

Disclosure information not submitted.
John Cush, MD

Executive Editor
RheumNow
Dallas, TX, United States

Disclosure(s): No financial relationships to disclose

Please join us for the latest in the understanding and management of Axial Spondyloarthritis and Psoriatic Arthritis at the annual SPARTAN GRAPPA ASAS symposium.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of OHSU School of Medicine. The OHSU School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. OHSU School of Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:

After participating in this CME activity, the learner will be kept up-to-date with recent advancements in the fields of axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA).
After participating in this CME activity, the learner will be able to recognize the challenges in evaluating and managing cases of refractory spondyloarthritis.
After participating in this CME activity, the learner will understand the safety concerns of JAK inhibitors as they relate to axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA).